Editorial: Treatments continue to improve. The challenge now facing ministers is hugely unequal outcomes ...

Huge improvements in prevention, diagnosis and treatment have driven the fall, Cancer Research UK says ...

Long-term results from a phase 2 study presented at the 27th European Congress on Gynaecological Oncology (ESGO 2026) in Hong ...

Cancers affecting the digestive system are becoming increasingly common worldwide. Many of these cancers develop slowly and may not cause clear symptoms in the early stages. Because the signs often ...

“Large-scale efforts need to be made" in the fight against these cancers, said paper author Dr. Ju Dong Yang.

Akeso, Inc. (9926.HK) ('Akeso' or the 'Company') announced that the latest long-term survival analysis data from the China ...

Discover how lifestyle risks are impacting cancer cases in Singapore and the multi-faceted approach needed for effective ...

FDA grants priority review to T-DXd for high-risk HER2-positive early breast cancer with residual disease, after trial shows markedly better recurrence-free survival than T-DM1.

Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) announced on March 6, 2026 that the first patient has been successfully dosed in a Phase ? clinical study ...

Cancer has traditionally been considered a disease that affects older adults, but recent observations suggest a concerning shift. Increasingly, more cases are being diagnosed in individuals under the ...

Background Gastric outlet obstruction syndrome (GOOS) is a clinically significant condition often associated with advanced malignancies, particularly gastric and pancreatic cancers. Management ...

CAR T-cell immunotherapy improved progression-free and overall survival in patients with relapsed or refractory marginal zone ...